Close Menu

Xagenic

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Molecular diagnostics startup Xagenic today announced the closing of a Series A financing round that raised C$10 million (US$10 million).

Xagenic's technology uses nanostructured microelectrodes to create highly sensitive nucleic acid sensors that it claims can detect DNA and RNA "at record-breaking speed."

The firm is creating a class of chip-based molecular diagnostics that rely on nanostructured microelectrodes to achieve "highly sensitive nucleic acid sensors that detect DNA and RNA with record-breaking speed."

Pages

Researchers uncovered the HIV virus within a tissue sample collected in 1966, the Atlantic reports.

Nature News reports there are a handful of clinical trials underway to evaluate vaginal microbiome seeding of newborns born via caesarian section.

The Washington Post writes that humans may have contributed to the extinction of cave bears some 20,000 years ago.

In PLOS this week: gene variant may protect against trypanosomiasis, GLIS3 role in type 2 diabetes, and more.